Recently, the "2025 Annual Insight Assessment of the Medical Device Industry Innovation Ecosystem" organized and initiated by the National High-Performance Medical Device Innovation Center was officially released. This assessment comprehensively covers the entire chain of technological research and development,成果转化， and market application， clearly outlining the panoramic picture of China's medical device industry's innovation ecosystem， and injecting continuous impetus for the high-quality development of the industry.
After a period of more than three months of collection, selection, and rigorous reviews by industry experts, Ying Sifeiying, with its self-developed wireless core technology breakthrough, full-scenario industrial collaboration, and high clinical value implementation, has consecutively ranked among the top 100 in the annual list, and continues to be listed in the "2025 Medical Device Industry Emerging Enterprises 100 Strong Innovation Index".
It is worth noting that this assessment has profoundly highlighted the industry trend of "early investment, small-scale investment, and investment in hard technologies": Among the 100 enterprises evaluated, as many as 71 were in the early stages (from seed round to A round, including A+, A++ etc.). The re-selection of Yingseifeying further confirms its status as a "future star" with core original technologies, demonstrating strong innovation potential and development resilience even during the initial growth stage.
As a pioneer in wireless medical technology, Inspire Imaging has mastered its own core wireless technology and has overcome key challenges in the wireless image transmission industry. Its core product, the intelligent wireless endoscope system, has achieved multiple technological innovations: integrating the camera host, light source host, and power supply into one unit, the size has been reduced to 1/20 of that of traditional equipment, with an ultra-small design that is suitable for various clinical scenarios; it has pioneered an ultra-low latency wireless transmission mode, perfectly meeting the precise operation requirements of minimally invasive surgeries and outpatient examinations; relying on the Starlink interconnection capability, it provides a feasible solution for remote mobile medical services in remote areas, making high-quality medical resources accessible to a wider range of scenarios.
Based on the clinical demand orientation, Yingseifeiying has continuously advanced technological iterations and product upgrades. Currently, the products have been widely applied in urology, orthopedics, gynecology, otorhinolaryngology and other departments of many hospitals worldwide, receiving high clinical recognition; at the same time, it has successfully broken through the boundaries of traditional diagnosis and treatment, opening up a new path of precise minimally invasive medical care in the pet and livestock fields, effectively promoting the upgrading of the veterinary diagnosis and treatment industry.
Currently, the annual "Top 100 Innovative Enterprises in the Medical Device Industry Index" has gradually become a valuable benchmark for measuring the annual innovation vitality and future competitiveness of China's medical device industry. It has identified and gathered a hundred innovative entities that represent the future of the industry and have growth potential.
In the future, Ying Sifeiying will always base itself on core technological innovation, focus on the core pain points of minimally invasive diagnosis and remote medical services, continuously iterate the wireless medical product portfolio, and expand the boundaries of cross-domain application scenarios. We will further deepen the collaboration among industry, academia, research and application, promote the efficient transformation of technical achievements into clinical value, and provide more compact, reliable, and practical medical solutions to empower the precise diagnosis capabilities of all levels of medical institutions, facilitate the upgrading of grassroots medical services and special scenario medical services, and inject more vitality into the construction of China's medical device innovation ecosystem.